Added to YB: 2024-08-01
Pitch date: 2024-07-28
1681.HK [bullish]
Consun Pharmaceutical Group Limited
+186.94%
current return
Author Info
Deep Value Investments makes long-term investments in in stocks where assets or cashflow are undervalued or something will happen to drive the price up. Sign up for the newsletter.
Company Info
Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
Market Cap
HKD 8.9B
Pitch Price
HKD 5.18
Price Target
N/A
Dividend
5.15%
EV/EBITDA
5.38
P/E
9.78
EV/Sales
1.88
Sector
Pharmaceuticals
Category
value
Mid Year 2024 Review +10.5% / 9.3% a few new ideas - Consun Pharmaceutical Group Limited
1681.HK Consun Pharma: PE 6, 10% yield. Half market cap in cash. Aging China pop tailwind. Main rev from traditional liver med granules, off-patent but strong brand. Gov reducing co-pays. Low trust society favors brand loyalty. China integrates trad & Western medicine. 1.5% portfolio weight, may increase.
Read full article (1 min)